Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 21, 2020
Previous Article Next Article

Modulating the solubility and pharmacokinetic properties of 5-fluorouracil via cocrystallization

Author affiliations

Abstract

5-Fluorouracil (5FU) is a classical anti-metabolic drug with broad-spectrum antitumor effects. However, the oral absorption of 5FU is incomplete with a short biological half-life and an obvious peak-valley phenomenon, leading to the frequent administration requirement and severe side effects. Herein, a pharmaceutical cocrystallization approach based on crystal engineering was employed to modulate the pharmacokinetic properties of 5FU by changing its aqueous solubility. Four cocrystals of 5FU with a group of dihydroxybenzoic acids were synthesized and characterized. The powder dissolution experiments showed that all the cocrystals exhibited different aqueous solubilities and dissolution rates in comparison with pure 5FU. As compared to pure 5FU, the apparent solubility values of two cocrystals were increased by 34% and 11% while those of the other two cocrystals were reduced by 27% and 51%, respectively. The pharmacokinetic parameters of all the cocrystals, including Cmax, tmax, MRT0–t, t1/2 and AUC0–t, as well as the shape of the pharmacokinetic curves, were accordingly altered in the in vivo pharmacokinetic study. This study has important implications for using cocrystallization techniques to modulate the pharmacokinetic properties of drugs with undesirable oral absorption, especially to avoid the in vivo peak-valley effect and reduce side effects in clinical practice.

Graphical abstract: Modulating the solubility and pharmacokinetic properties of 5-fluorouracil via cocrystallization

Back to tab navigation

Supplementary files

Article information


Submitted
17 Mar 2020
Accepted
22 Apr 2020
First published
24 Apr 2020

CrystEngComm, 2020,22, 3670-3682
Article type
Paper

Modulating the solubility and pharmacokinetic properties of 5-fluorouracil via cocrystallization

X. Dai, C. Wu, J. Li, L. Liu, X. He, T. Lu and J. Chen, CrystEngComm, 2020, 22, 3670
DOI: 10.1039/D0CE00409J

Social activity

Search articles by author

Spotlight

Advertisements